Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Rebaudioside A has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Rebaudioside A is sweet at concentrations far too low to provide any volume, so a bulking sweetener carries it in powders and tablets. Erythritol is the usual partner because its cooling effect partly masks the lingering finish steviol glycosides are known for. This is standard practice in the category rather than a physiological interaction.
In powdered blends inulin does the volume job that a high-intensity sweetener cannot. It is also fermented by colonic Bacteroides, the group most implicated in hydrolysing steviol glycosides to steviol. So the pairing is both a texture decision and a shift in the fermentation environment where the sweetener is processed.
Rebaudioside A passes the small intestine essentially intact and is hydrolysed by gut bacteria, mainly Bacteroides species, to free steviol which is then absorbed and glucuronidated. Changing the microbial community plausibly changes the rate of that step. Whether an added probiotic strain shifts it measurably has not been shown, so this is mechanistic reasoning about a documented pathway.
Rebaudioside A is heat and pH stable across the range protein powders see, which is why it displaced older sweeteners in the category. Protein systems also carry their own bitterness, and glycoside blends are tuned against it. This is formulation convention.
Rebaudioside A carries a bitter and licorice-like tail alongside its sweetness, and caffeine is a separate bitterant. In energy drinks and coffee formats the two bitter signals stack rather than cancel, which is why blends and masking agents are used. Purely a sensory interaction with no metabolic component.
Nothing specific on file for Rebaudioside A. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 4 we read for Rebaudioside A. The full linked list is below.
4 sources behind our Rebaudioside A verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.